Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Pancreatic Cancer Resectable 1 Neoplasms, Second Primary 1 Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Pemetrexed 10 Cisplatin 9 Erlotinib Hydrochloride 8 Carboplatin 7 icotinib 5 Gefitinib 5 Docetaxel 5 endostar protein 3 Zoledronic Acid 3 Radiotherapy 3 Paclitaxel 3 Gemcitabine 3 Endostatins 3 Afatinib 3 tislelizumab 2 pembrolizumab 2 osimertinib 2 lorlatinib 2 flurbiprofen axetil 2 dexamethasone 21-phosphate 2 atezolizumab 2 Vinorelbine 2 Surgical Procedures, Operative 2 Saline Solution 2 Nivolumab 2 Drug Therapy 2 Dexamethasone 2 Chemoradiotherapy 2 trametinib 1 spartalizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Carcinoma, Non-Small-Cell Lung × Antineoplastic Agents × Clear all

NCT06357598 2024-04-10

PILOT

The Affiliated Hospital of Qingdao University

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡